Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 2, 1996, Pages 111-116

  Naidu, S ^a   Payne, A J ^a   Moodley, J ^a   Hoffmann, M ^b   Gouws, E ^c  

^a MRCIUN Pregnancy Hypertension Research Unit   (South Africa)

^b UNIVERSITY OF NATAL   (South Africa)

^c MRC Institute of Biostatistics   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE; PHENYTOIN;

ARTICLE; BLOOD FLOW VELOCITY; BRAIN CIRCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; ECLAMPSIA; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULTRASOUND;

ADOLESCENT; ADULT; ANTICONVULSANTS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; ECLAMPSIA; FEMALE; HUMANS; MAGNESIUM SULFATE; PHENYTOIN; PREGNANCY; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0030039301     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09660.x     Document Type: Article

References (32)

1. Moodley J, Daya P. Eclampsia: a continuing problem in developing countries. Inr J Gynecol Obstet 1994; 44: 9–14.
2. Donaldson JO. The brain in eclampsia. Hyperten Pregn 1994; 13: 115–133.
3. Sibai BM, Ramanathan J. The case for magnesium sulfate in pre-eclampsia and eclampsia. Int J Obstet Anaesthesia 1992; 1: 167–175.
4. Belfort MA, Moise KJ. Effect of magnesium sulfate on maternal brain blood flow in pre-eclampsia: a randomised placebo controlled study. Am J Obstet Gynecol 1992; 167: 661–666.
5. Slater RIA, Wilcox FL, Smith DW. Phenytoin infusion in severe pre-eclampsia. Lancet 1987; i: 1417–1421.
6. Ryan G, Lange IR, Naugler MA. Clinical experience with phenytoin prophylaxis in severe pre–eclampsia. Am J Obster Gynecol 1989; 161: 1297–1304.
7. Repke JT, Friedman SA, Kaplan PW. Prophylaxis of eclamptic seizures: current controversies. Clin Obstet Gynecol 1992; 35: 365–374.
8. Dommisse J. Phenytoin sodium and magnesium sulphate in the management of eclampsia. Br J Obster Gynaecol 1990; 97: 99–101.
9. Naidu S, Moodley J, Botha J, McFadyen L. The efficacy of phenytoin in relation to serum levels in severe pre–eclampsia and eclampsia. Br J Obstet Gynaecol 1992; 99: 881–886.
10. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 1982; 51: 769–774.
11. Hennerici M, Rautenberg W, Sitzer G, Schwarts AS. Transcranial Doppler ultrasound for the assessment of intracranial arterial flow velocity–part 1. Examination technique and normal values. Surg Neurol 1987; 27: 439–448.
12. Newell DW, Aaslid R. Transcranial Doppler normal values and physiological variables. In Transcranial Doppler. New York : Raven Press Ltd, 1992: 41–48.
13. Dahl A, Russell D, Nyberg-Hansen R, Rootwelt K. Effect of nitroglycerine on cerebral circulation measured by transcranial Doppler and SPECT. Stroke 1989; 20: 1733–1736.
14. Kyle PM, De Swiet M, Buckley D, Serra, Serra V, Redman CWG. Noninvasive assessment of the maternal cerebral circulation by transcranial Doppler ultrasound during angiotensin II infusion. Br J Obsret Gynaecol 1993; 100: 85–91.
15. Moodley J, Naicker RS, Mankowitz E. Eclampsia-a method of management. S Afr Med J 1983: 63: 530–535.
16. Pritchard JA, Cinningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynaecol 1984; 148: 951–963.
17. Gosling RG, Dunbar G, King DH. The quantitative analysis of occlusive peripheral arterial disease by a non-intrusive ultrasonic technique. Angiology 1971; 22: 52–55.
18. Will AD, Lewis KL, Hinshaw DB et al. Cerebral vasoconstriction in toxemia. Neurology 1987; 37: 1555–1557.
19. Trommer BL, Homer D, Mikhael M. Cerebral vasospasm and eclampsia. Stroke 1988; 19: 326–329.
20. Lewis LK, Hinshaw DB, Will AD et al. CT and angiographic correlation of severe neurological disease in toxaemia of pregnancy. Neuroradiology 1989; 30: 59–64.
21. Barton JR, Sibai BM. Cerebral pathology in eclampsia. Clin Perinatol 1991; 18: 891–900.
22. Newell DW, Grady MS, Eskridge JM, Winn HR. Distribution of angiographic vasospasm after subarachnoid haemorrhage: implications for diagnosis by transcranial Doppler ultrasonography. Neurosurgery 1990; 27: 574–575.
23. Donaldson JO. Neurology of Pregnancy. Bailliere Tindall, 1989, London, pp. 269–310.
24. Kaplan PW, Lesser RP, Fisher RS, Repke JT, Hanley DF. A continuing controversy: magnesium sulphate in the treatment of eclamptic seizures. Arch Neurol 1990; 47: 1031–1032.
25. Dyckner T, Wester PO. Effects of magnesium on blood pressure. Br Med J 1983; 286: 1847–1849.
26. Levine BS, Coburn JW, Magnesium the minnie antagonist of calcium. N Engl J Med 1984; 310: 1253–1254.
27. Goldman RS, Finkbeiner SM. Therapeutic use of magnesium sulfate in selected cases of cerebral ischaemia and seizure. N Engl J Med 1988; 319: 1224–1225.
28. Rall TW, Schleifer LS. Drugs effective in the therapy of the epilepsies. In Goodman and Gilman's The Pharmacological Basis of Therapeutics. Oxford : Pergamon Press, 1991: 446–472.
29. Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial: Lancet 1995; 345: 1455–1463.
30. Robson SC, Walkinshaw S, Redfern N, De Swiet M, Rodeck C. Seizure prophylaxis using phenytoin in severe pre-eclampsia and eclampsia. J Obstet Gynaecol 1990; 10: 449–450.
31. Gerthoffer WT, Shafer PG, Taylor S. Selectivity of phenytoin and dihydropyridine calcium channel blockers for relaxation of the basilar artery. J Cardiovasc Pharmacol 1987; 10: 9–15.
32. Wilder BJ, Bruni J. Mechanisms of action of antiepileptic drugs. Clin Neuropharmacol 1982; 5: 23–43.